Sanofi SA (France) Top Management
SAN Stock | EUR 92.09 0.01 0.01% |
Sanofi SA employs about 91.6 K people. The company is managed by 10 executives with a total tenure of roughly 213671 years, averaging almost 21367.0 years of service per executive, having 9157.3 employees per reported executive. Analysis of Sanofi SA's management performance can provide insight into the company performance.
JeanBaptiste Chatillon Insider Ex CFO |
Roy Papatheodorou Insider Gen VP |
Sanofi |
Sanofi SA Management Team Effectiveness
The company has return on total asset (ROA) of 0.0559 % which means that it generated a profit of $0.0559 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1177 %, meaning that it generated $0.1177 on every $100 dollars invested by stockholders. Sanofi SA's management efficiency ratios could be used to measure how well Sanofi SA manages its routine affairs as well as how well it operates its assets and liabilities.Sanofi SA Workforce Comparison
Sanofi SA is currently regarded as top stock in number of employees category among its peers. The total workforce of Drug Manufacturers—General industry is at this time estimated at about 617,514. Sanofi SA retains roughly 91,573 in number of employees claiming about 15% of equities under Drug Manufacturers—General industry.
The company has Profit Margin (PM) of 0.18 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.24 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.24. Sanofi SA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Sanofi SA Price Series Summation is a cross summation of Sanofi SA price series and its benchmark/peer.
Sanofi SA Notable Stakeholders
A Sanofi SA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sanofi SA often face trade-offs trying to please all of them. Sanofi SA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sanofi SA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
JeanBaptiste Chatillon | Ex CFO | Profile | |
Roy Papatheodorou | Gen VP | Profile | |
Josephine Fubara | Chief Care | Profile | |
Paul Hudson | CEO Director | Profile | |
Bruno Mnard | Chief officer | Profile | |
Pierre Chancel | Sr Marketing | Profile | |
Laurent Gilhodes | Principal Accounting | Profile | |
Dante Beccaria | Global VP | Profile | |
Eva SchaeferJansen | Head Relations | Profile | |
Josep Catlla | Head Communications | Profile |
About Sanofi SA Management Performance
The success or failure of an entity such as Sanofi SA often depends on how effective the management is. Sanofi SA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sanofi management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sanofi management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. Sanofi was incorporated in 1994 and is headquartered in Paris, France. SANOFI operates under Drug ManufacturersGeneral classification in France and is traded on Paris Stock Exchange. It employs 99412 people.
Please note, the presentation of Sanofi SA's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sanofi SA's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sanofi SA's management manipulating its earnings.
Sanofi SA Workforce Analysis
Traditionally, organizations such as Sanofi SA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sanofi SA within its industry.Sanofi SA Manpower Efficiency
Return on Sanofi SA Manpower
Revenue Per Employee | 495.7K | |
Revenue Per Executive | 4.5B | |
Net Income Per Employee | 91.4K | |
Net Income Per Executive | 837.1M |
Complementary Tools for Sanofi Stock analysis
When running Sanofi SA's price analysis, check to measure Sanofi SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi SA is operating at the current time. Most of Sanofi SA's value examination focuses on studying past and present price action to predict the probability of Sanofi SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi SA's price. Additionally, you may evaluate how the addition of Sanofi SA to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |